CDC and FDA Declares Joint Statement in Johnson & Johnson COVID vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are giving a second thought and declaring a pause on the Johnson & Johnson COVID vaccine this April 2021 for the safety of the people.

COVID19 vaccine is given top priority these days. People worldwide are trying all kinds of immune boosters to help them stay away from viruses. Pharma companies are giving in their best to come out with efficient vaccines and medicines that can help the general public. The governments of all countries worldwide are executing various plans that can help stop the spread of coronavirus.  Right from imposing restrictions to lockdown, the government has put in a lot of effort to curb coronavirus spread.

The authorization of the COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have gone ahead and given the green flag to COVID  vaccines for use by the general public worldwide. They have approved COVID vaccines under the Emergency Authorization Use for the betterment of the people. The  Food and Drug Administration (FDA) is working to address the concerns about vaccines among people, to protect and promote the health of the entire population. They are focussing on the strategies that address health disparity.

Side effects of the COVID vaccine are a major concern 

The use of the coronavirus vaccine has brought about a major concern of side effects in immunized people. The major fear of blood clots has been rising among the people about the coronavirus vaccine. This has been noticed in people receiving the Johnson & Johnson (J&J) vaccine which has been administered. The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are reviewing data of the six cases reported by the USA  where cases of rare and severe blood clots in the individual have been seen after receiving the  Johnson & Johnson (J&J) vaccine. A type of blood clot called Cerebral Venous Sinus Thrombosis(CVST) was seen in a combination of low platelet count, Thrombocytopenia. 

Details of the six cases detected an under review by The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)

All six cases which are under review were seen in the age group between 18 - 48. The symptoms of the blood clot called Cerebral Venous Sinus Thrombosis(CVST) and Thrombocytopenia occurred between 6 - 13 days after vaccination. Administering the COVID vaccine is led to this side effect of blood clots which needs immediate medical attention by The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The general conventional treatment of administering the anticoagulant called heparin is used to treat blood clots may be dangerous. We need to make sure that the vaccine has no interactions with the conventional treatment that is used by the patients. 

FDA ensures efficacy and safety of COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)  will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) to further review these six cases of blood clot side effects with COVID vaccine that has come into light this April 2021. FDA will review the analysis and also instigate the cases. Until the process is complete and under review, The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are recommending a pause to the use of the vaccine which is the need of the hour. This is a very important announcement by the FDA to ensure that healthcare professionals are aware of the side effects of this vaccine.

Tags : #medicircle #myhealth #FDA #CDC #COVIDvaccine #COVIDvaccinesideeffects

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026